Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 × 2 factorial trial
Journal of Neurology · 2024-08 · 271 (8) · 5122-5136
DOI: 10.1007/s00415-024-12433-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neurology, online erschienen am 31.05.2024. Verfasst von Rongrong Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Trigeminal Neuralgia, Carbamazepine, Electroacupuncture, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
Background
Trigeminal neuralgia (TN) is difficult to treat due to its severe pain intensity and recurring episodes, which significantly impact quality of life.
Objectives
We aimed to assess the effectiveness of electroacupuncture (EA) in alleviating the pain intensity in TN, and to determine whether EA combined with low-dosage carbamazepine (CBZ) has a synergistic effect.
Methods
A multi-centre, randomized, 2 × 2 factorial trial was conducted. Participants who met the inclusion criteria received active EA or sham EA for 60 min, three times a week for four weeks; CBZ (300 mg per day) or placebo for four weeks. The primary outcome was the change in visual analog scale (VAS) score from baseline to weeks 2, 4, 16, and 28. Secondary outcomes included quality of life and adverse events.
Results
A total of 120 participants (75 females and 45 males; mean (SD) age, 58.5 (15.3) years) were included. The main effects of EA and CBZ were significant ( P < 0.001), and there was a significant interaction was identified between the interventions ( P = 0.041). Participants who received EA (mean difference [MD], −0.3 [95% CI, −0.40 to −0.20] at week 2; −1.6 [−1.70 to −1.50] at week 4; −1.1 [−1.31 to −0.89] at week 16; −0.8 [−1.01 to −0.59] at week 28), CBZ (MD, −0.6 [95% CI, −0.70 to −0.50] at week 2; −0.9 [−1.03 to −0.77] at week 4, −0.2 [−0.41 to 0.01] at week 16, 0.2 [−0.01 to 0.41] at week 28), and the combination of both (MD, −1.8 [95% CI, −1.90 to −1.70] at week 2; −3.7 [−3.83 to −3.57] at week 4, −3.4 [−3.61 to −3.19] at week 16, −2.9 [−3.11 to −2.69] at week 28) had a greater reduction in VAS score over the treatment phase than their respective control groups (sham EA, placebo, and sham EA plus placebo). EA-related adverse events (6/59, 10.17%) were lower than that of CBZ (15/59, 25.42%) during the whole phases.
Conclusions
EA or CBZ alone are effective treatments for TN, while the combination of EA and low-dosage CBZ exerts a greater benefit. These findings in this trial demonstrate that the combination of EA and low-dosage CBZ may be clinically effective under certain circumstances.
Trial registration
NCT03580317.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
- The Third Clinical Medical College of Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang, China.
- Department of Neurobiology and Acupuncture Research, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, 219 Moganshan Road, Hangzhou, Zhejiang, China.
- The Third Clinical Medical College of Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang, China. liangyiwww@126.com.
- Department of Neurobiology and Acupuncture Research, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, 219 Moganshan Road, Hangzhou, Zhejiang, China. liangyiwww@126.com.
Förderung
- Zhejiang Traditional Chinese Medicine Administration
Zitieren
APA
Li, R., Sun, J., Luo, K., Luo, N., Sun, R., Gao, F., Wang, Y., Xia, Y., Li, X., Chen, L., Ma, R., Shao, X., Liang, Y., & Fang, J. (2024). Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 × 2 factorial trial. Journal of Neurology, 271(8), 5122-5136. https://doi.org/10.1007/s00415-024-12433-x
Vancouver
Li R, Sun J, Luo K, Luo N, Sun R, Gao F, et al. Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 × 2 factorial trial. Journal of Neurology. 2024;271(8):5122-5136. doi:10.1007/s00415-024-12433-x
BibTeX
@article{Li2024,
author = {Li, Rongrong and Sun, Jing and Luo, Kaitao and Luo, Ning and Sun, Ruohan and Gao, Feng and Wang, Yiyi and Xia, Yunfan and Li, Xiaoyu and Chen, Lifang and Ma, Ruijie and Shao, Xiaomei and Liang, Yi and Fang, Jianqiao},
title = {Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 × 2 factorial trial},
journal = {Journal of Neurology},
year = {2024},
volume = {271},
number = {8},
pages = {5122--5136},
doi = {10.1007/s00415-024-12433-x}
}
EUVIMED